3003新葡的京集团
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2010.05.19
内幕信息及知情人登记和报备制度(2010年5月)
2010.05.19
关于使用部分超额募集资金归还银行贷款和补充永久性流动资金的公告
2010.05.19
重大信息内部报告制度(2010年5月)
2010.05.19
第一届董事会第十八次会议决议公告
2010.05.19
关于签订《募集资金三方监管协议》的公告
2010.05.15
澄清公告
2010.05.13
交易异常波动公告
2010.05.05
2010年第一季度财务资料
2010.05.05
首次公开发行上市公告书
2010.05.05
北京市中伦律师事务所关于公司首次公开发行的申请在深圳交易所上市的法律意见...
第一页
上一页
150
151
152
153
154
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.